HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John C Waterton Selected Research

bisbenzimide ethoxide trihydrochloride (Hoechst 33342)

10/2012Evaluation of novel combined carbogen USPIO (CUSPIO) imaging biomarkers in assessing the antiangiogenic effects of cediranib (AZD2171) in rat C6 gliomas.
7/2011Investigating temporal fluctuations in tumor vasculature with combined carbogen and ultrasmall superparamagnetic iron oxide particle (CUSPIO) imaging.
12/2008Longitudinal in vivo susceptibility contrast MRI measurements of LS174T colorectal liver metastasis in nude mice.
11/2007Susceptibility contrast magnetic resonance imaging determination of fractional tumor blood volume: a noninvasive imaging biomarker of response to the vascular disrupting agent ZD6126.
5/2005Acute tumor response to ZD6126 assessed by intrinsic susceptibility magnetic resonance imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John C Waterton Research Topics

Disease

29Neoplasms (Cancer)
10/2018 - 06/2003
6Hypoxia (Hypoxemia)
03/2019 - 12/2008
6Necrosis
01/2019 - 06/2004
4Prolactinoma (Prolactinomas)
08/2013 - 03/2004
3Interstitial Lung Diseases (Interstitial Lung Disease)
12/2020 - 10/2018
3Chronic Obstructive Pulmonary Disease (COPD)
01/2016 - 11/2014
2Fibrosis (Cirrhosis)
12/2020 - 01/2019
2Inflammation (Inflammations)
12/2020 - 09/2017
2Knee Osteoarthritis
01/2019 - 01/2010
2Polyploidy
04/2017 - 01/2012
2Glioma (Gliomas)
05/2014 - 10/2012
2Lung Neoplasms (Lung Cancer)
01/2012 - 06/2009
2Colorectal Neoplasms (Colorectal Cancer)
07/2011 - 12/2008
1Lung Injury
12/2020
1Drug-Related Side Effects and Adverse Reactions
12/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019
1Renal Cell Carcinoma (Grawitz Tumor)
01/2018
1Lupus Nephritis
11/2017
1Synovitis
09/2017
1Rheumatoid Arthritis
09/2017
1Colonic Neoplasms (Colon Cancer)
04/2017
1Prostatic Neoplasms (Prostate Cancer)
10/2016
1Lung Diseases (Lung Disease)
01/2016
1Glioblastoma (Glioblastoma Multiforme)
05/2014
1Liver Diseases (Liver Disease)
10/2013
1Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2013
1Vascular Remodeling
10/2012
1Osteoarthritis
04/2009
1Disease Progression
04/2009
1Neoplasm Metastasis (Metastasis)
12/2008
1Congenital Abnormalities (Deformity)
11/2008
1Hypercholesterolemia
03/2008
1Carotid Stenosis (Carotid Artery Stenosis)
03/2008
1Fibrosarcoma
07/2006
1Hyperphagia (Overeating)
01/2005
1Obesity
01/2005
1Dyslipidemias (Dyslipidemia)
01/2005
1Insulin Resistance
01/2005
1Pathologic Constriction (Stenosis)
11/2004

Drug/Important Bio-Agent (IBA)

34Biomarkers (Surrogate Marker)IBA
12/2020 - 05/2005
8Oxygen (Dioxygen)IBA
03/2019 - 11/2009
7Pharmaceutical PreparationsIBA
12/2020 - 06/2004
6carbogenIBA
03/2019 - 01/2009
6N-acetylcochinol-O-phosphateIBA
11/2007 - 03/2004
5ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA
10/2016 - 11/2007
5bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA
10/2012 - 05/2005
4Contrast MediaIBA
01/2018 - 11/2007
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2012 - 06/2003
2Eosine Yellowish-(YS) (Eosin)IBA
01/2019 - 12/2008
22- ((3- ((4- ((5- (2- ((3- fluorophenyl)amino)- 2- oxoethyl)- 1H- pyrazol- 3- yl)amino)quinazolin- 7- yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphateIBA
04/2017 - 01/2012
2pimonidazoleIBA
10/2012 - 12/2008
2cediranib (AZD2171)IBA
10/2012 - 01/2012
1Indicators and Reagents (Reagents)IBA
03/2019
1Anti-Bacterial Agents (Antibiotics)IBA
10/2018
1Amiodarone (Amiodarona)FDA LinkGeneric
10/2018
1fostamatinibIBA
09/2017
1Adalimumab (Humira)FDA Link
09/2017
1alovudineIBA
01/2017
1thymidine kinase 1IBA
01/2017
1Hydralazine (Apresoline)FDA LinkGeneric
02/2016
1CollagenIBA
04/2015
1Adrenal Cortex Hormones (Corticosteroids)IBA
11/2014
1Budesonide (Pulmicort)FDA LinkGeneric
11/2014
1Formoterol Fumarate (Oxis)FDA Link
11/2014
1BilirubinIBA
10/2013
1Bile Acids and Salts (Bile Acids)IBA
10/2013
1Hemoglobins (Hemoglobin)IBA
08/2013
1Hormones (Hormone)IBA
01/2013
1salicylhydroxamic acid (SHAM)IBA
01/2012
1Aurora Kinase BIBA
01/2012
1AZD 1480IBA
01/2012
1Matrix Metalloproteinases (MMPs)IBA
04/2009
1Doxycycline (Periostat)FDA LinkGeneric
04/2009
1Hematoxylin (Haematoxylon)IBA
12/2008
1Rosuvastatin Calcium (Crestor)FDA Link
03/2008
1LDL CholesterolIBA
03/2008
1Dihydrotachysterol (AT 10)IBA
05/2007
1Phosphorylcholine (Phosphocholine)IBA
07/2006
1Choline (Choline Chloride)IBA
07/2006
1Lactic Acid (Lactate)FDA LinkGeneric
07/2006
1Growth Hormone (Somatotropin)IBA
01/2005
1Protons (Proton)IBA
11/2004
1Phosphates (Orthophosphate)IBA
03/2004
1N-acetylcolchinolIBA
03/2004
1ZD 4190IBA
06/2003

Therapy/Procedure

7Therapeutics
03/2019 - 05/2007
3Aftercare (After-Treatment)
10/2012 - 05/2005
2Drug Therapy (Chemotherapy)
03/2019 - 01/2012
2Intravenous Administration
10/2016 - 07/2011
1Radiotherapy
03/2019
1Neoadjuvant Therapy
01/2019
1Drug Tapering
06/2003